Side Effects of Immunosuppressive Treatments in Primary Glomerulonephritis
- 27 December 2024
- journal article
- Published by Dokuz Eylul Universitesi Tip Fakultesi Dergisi in Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi
- Vol. 38 (3) , 169-177
Abstract
Background: It is imperative to closely monitor patients for adverse effects of immunosuppressive (IS) agents, widely used in treating glomerulonephritis (GN). Our study aimed to investigate the occurrence of any drug-related adverse events in patients with primary GN, explicitly focusing on IS. Methods: The present study analyzed 162 adult GN patients treated with IS drugs. The study scrutinized the demographic and clinical profiles of the patients, laboratory findings, and any side effects associated with IS drugs. We further investigated the patients for frequency and nature of infections, musculoskeletal and gastrointestinal symptoms, thromboembolism, new-onset diabetes, avascular necrosis, neuropsychiatric side effects, and premalignant conditions. Results: The study comprised a diverse group of patients with a male majority of 51.9% and a mean age of 37.2±12.9 years. The patients were under clinical observation for an average of 69.6±40.1 months, and during the treatment, 71% experienced at least one adverse effect. After evaluating the data, we did not find a significant correlation between the GN type and the presence of side effects. Research demonstrates that patients receiving corticosteroids (CS) exhibit a higher incidence of myopathy than those receiving other IS therapies (p=0.001). Hypoalbuminemia (OR: 2.05; 95% CI: 1.82–2.28; p =0.001) and steroid treatment (OR: 1.04; 95% CI: 1.01–1.06; p = 0.009) are significantly associated with increased risk of adverse outcomes. Conclusion: In cases of GN, it is not unusual for patients to encounter adversities associated with IS treatment, primarily when there is a comorbidity of hypoalbuminemia and CS exposure. The probability of these side effects occurring may increase under such circumstances. Main Points: • Patients diagnosed with GN should undergo meticulous monitoring to detect any potential adverse effects that may arise from the administration of IS agents • The probability of experiencing side effects is higher when hypoalbuminemia and CS exposure are present. • The present study suggests no discernible correlation between the type of GN and side effects.Keywords
Funding Information
- Funding Sources: The authors did not receive any funding for this study (Tarih ve Sayı: 21.11.2023-2265277)
This publication has 19 references indexed in Scilit:
- Immunosuppression Exposure and Risk of Infection-Related Acute Care Events in Patients With Glomerular Disease: An Observational Cohort StudyKidney Medicine, 2022
- Steroid-Associated Side Effects in Patients With Primary Proteinuric Kidney DiseaseKidney International Reports, 2019
- Primary glomerulonephritidesThe Lancet, 2016
- Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formationBone, 2007
- New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta-AnalysisAmerican Journal of Transplantation, 2004
- DIABETES MANAGEMENT IN SPECIAL SITUATIONSEndocrinology and Metabolism Clinics of North America, 1997
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- Mycophenolic acid for psoriasisJournal of the American Academy of Dermatology, 1987
- Association of Adrenocorticosteroid Therapy and Peptic-Ulcer DiseaseNew England Journal of Medicine, 1983
- Effect of Corticosteroids on Cataract FormationArchives of Ophthalmology (1950), 1980